EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Identification of new human monogenic disorders and implementation of genomic medicine in sick newborn infants

Toshiki Takenouchi iD

Pediatrics International · 2026

DOI: 10.1111/ped.70327 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pediatrics International, 2026. Verfasst von Toshiki Takenouchi. Beteiligte Einrichtung: Department of Pediatric Neurology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan. Hauptthemen laut MEDLINE: Genetic Testing, Genomic Medicine, Genetic Diseases, Inborn. Die Arbeit nennt 24 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the past few decades, advances in genomic analysis techniques and bioinformatics have enabled the identification of many new human monogenic diseases. In 2015, the Japan Agency for Medical Research and Development launched a national project for undiagnosed diseases called the Initiative on Rare and Undiagnosed Diseases (IRUD). Through this project, we identified Takenouchi‐Kosaki syndrome (OMIM#616737), which is caused by specific pathogenic variants in CDC42 , a critical regulator of diverse cellular functions, and is clinically characterized by intellectual disability and macrothrombocytopenia. In addition to the identification of disease‐causing genes and new human monogenic disorders, significant progress has also been made in the clinical implementation of genomic medicine. In 2019, we launched a national project called Precise and Rapid Genetic Diagnosis and Treatability for Infants (Priority‐i) to provide rapid genetic diagnosis for sick newborns in neonatal intensive care units. It is our mission to apply the benefits of the latest advances in genomic medicine to the clinical care of newborns and children.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TestingGenomic MedicineGenetic Diseases, InbornHumansInfant, NewbornJapan

Stichwörter der Autor:innen

CDC42Takenouchi‐Kosaki syndromeexome sequencinginitiative on rare and undiagnosed diseasesprecise and rapid genetic diagnosis and treatability for infants

Autor:innen und Institutionen

  • Department of Pediatric Neurology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

ORCID-Profile: Toshiki Takenouchi

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science

Zitieren

APA

Takenouchi, T. (2026). Identification of new human monogenic disorders and implementation of genomic medicine in sick newborn infants. Pediatrics International. https://doi.org/10.1111/ped.70327

Vancouver

Takenouchi T. Identification of new human monogenic disorders and implementation of genomic medicine in sick newborn infants. Pediatrics International. 2026. doi:10.1111/ped.70327

BibTeX
@article{Takenouchi2026,
  author = {Takenouchi, Toshiki},
  title = {Identification of new human monogenic disorders and implementation of genomic medicine in sick newborn infants},
  journal = {Pediatrics International},
  year = {2026},
  doi = {10.1111/ped.70327}
}
Kostenlos starten →